Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Xtandi Still Faces Likely US Price Cut Even As It Avoids ‘March In’ Proceeding
Mar 24 2023
•
By
Michael McCaughan
Xtandi may have moved out of the frying pan and out of the fire on pricing. • Source: Shutterstock
More from Market Access
More from Pink Sheet